Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06895590 · ClinicalTrials.gov registry record
The HIgh-fidelity Hydraulic couPling Upper-arm Cuff Assessment of Limits, Safety, and Effectiveness (HIPULSE) Trial
A clinical trial of Intensive Care Unit (ICU) and Non-cardiac Surgical, sponsored by Philips Clinical & Medical Affairs Global.
- Recruiting
- Registry status
- 205
- Enrollment target
- 4
- Study locations
NCT06895590: Recruiting study of Intensive Care Unit (ICU) and Non-cardiac Surgical, sponsored by Philips Clinical & Medical Affairs Global.
NCT06895590 is a study of Intensive Care Unit (ICU) and Non-cardiac Surgical that is actively recruiting participants, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 205 participants. The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06895590, a study of Intensive Care Unit (ICU) and Non-cardiac Surgical, is actively recruiting participants, sponsored by Philips Clinical & Medical Affairs Global.
- RECRUITING
- Registry status
- 205 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to compare measurements of blood pressure (BP) and fluid responsiveness between the Philips AMC and invasive radial arterial line in surgical patients.
Primary Outcome
The comparison of systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) between the Philips AMC and radial arterial line.
Conditions Studied
Interventions
- DEVICE Philips Advanced Monitoring Cuff (i.e. AMC)
Study Locations (4)
North Carolina
- Duke University Health System - Durham
- Wake Forest Baptist Medical Center - Winston-Salem
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Bavaria
- LMU Klinikum , Campus Großhadern - München
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2025-10-02 |
| Est. Completion | 2026-02 |
What NCT06895590 shows while recruiting
NCT06895590 is an observational study that tracks outcomes without assigning an intervention. The registered 205 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Intensive Care Unit (ICU) appearing as the primary indexed condition, and to 1 intervention - of which Philips Advanced Monitoring Cuff (i.e. AMC) is the first listed.
NCT06895590 reports a single indexed study location in North Carolina, Massachusetts, Bavaria.
Frequently Asked Questions
What is clinical trial NCT06895590 about?
NCT06895590 is a clinical study titled "The HIgh-fidelity Hydraulic couPling Upper-arm Cuff Assessment of Limits, Safety, and Effectiveness (HIPULSE) Trial". The purpose of this study is to compare measurements of blood pressure (BP) and fluid responsiveness between the Philips AMC and invasive radial arterial line in surgical patients.
What is the current status of trial NCT06895590?
This trial is currently recruiting. The enrollment target is 205 participants. The study started on 2025-10-02. Estimated completion is 2026-02.
What conditions does trial NCT06895590 study?
This clinical trial studies the following conditions: Intensive Care Unit (ICU), Non-cardiac Surgical.
What interventions are being tested in trial NCT06895590?
The interventions under investigation include: Philips Advanced Monitoring Cuff (i.e. AMC) (DEVICE).
Who is sponsoring clinical trial NCT06895590?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06895590 being conducted?
This trial has 4 study locations across Massachusetts, North Carolina, Bavaria. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intensive Care Unit (ICU)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03457493 · 205 participants · Phase 1
The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy
- NCT05134857 · 205 participants · Phase 2
The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study
- NCT05181891 · 205 participants · Phase 2
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
- NCT05283811 · 205 participants · NA
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI